Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,122.6
-13.4 (-0.43%)

 

  • STI Straits Times Index
    3,122.6
    -13.4 (-0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.6
    -8.2 (-0.51%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,270.0
    38.5 (0.15%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,880.3
    0.3 (0.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,618.6
    -58.7 (-0.28%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,253.0
    -42.8 (-0.68%)
    Index delayed 10 minutes
  • KOR KOSPI
    1,964.7
    4.4 (0.22%)
    Index delayed 20 minutes
  • XAO XAO
    6,572.6
    -54.8 (-0.83%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 692.8M
  • Value: 977.8M
  • Rise: 147
  • Fall: 136
  • Unch: 553

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
ThaiBev0.925+0.035
YZJ Shipbldg SGD0.965-0.005
Spackman0.013-0.002
ESR-REIT0.520+0.010
Y Ventures0.101+0.008
Synagie0.168+0.008
Rex Intl0.077+0.001
SingTel3.190-0.030
Mapletree Com Tr2.080+0.010
Ascott Reit1.290-0.010

World Indices

World Indices
Name Last Change
Nasdaq 7,948.6 -54.2
HSI 26,270.0 +38.5
HSCEI 10,177.3 +44.5
Jakarta 6,253.0 -42.8
Nikkei 225 20,618.6 -58.6
SSE Comp 2,880.3 +0.3
Shanghai A 3,017.4 +0.3
Shanghai B 264.8 +0.2
PSE Comp 0.0
KOSPI 1,964.7 +4.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ORAGENICS INC ORAGENICS
Updated on 20 Aug 2019 (End of trading day)
Last (USD): 0.399 Change: +0.015 High: 0.410 Remarks: -
Change (%): +4.05 Low: 0.386
Open 0.400 Yesterday's Close 0.3831
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 616,229 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.22986 Trailing EPS (USD) e -0.30559 NAV (USD) b 0.3635
PE a - Trailing PE f - Price / NAV b 1.0966
Dividend (USD) d - Cash In Hand (USD) g 0.5220 Issued & Paid-up Shares c 46,125,000
Dividend Yield (%) d - Price / Cash In Hand g 0.764 Treasury Shares h -
Beta - 75 Daysi 0.845 R-Squared - 75 Days(%)i 0.33 Market Cap (M) 19.641
Beta - 500 Daysi 0.213 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 1.203
Piotroski F Score 2 Exchange Code OGEN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 118.53 Free Float (%) 90.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 May 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ORAGENICS INC NYSE American 19.641 - - 1.0966 -
Industry Biotechnology NYSE American 71.741 - - 2.8298 -
Local Peer 22ND CENTURY GROUP INC NYSE American 194.216 - - 3.1168 -
Local Peer PFENEX INC NYSE American 166.350 - - 3.2107 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 151.139 - - - -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 139.783 5.659 - 8.7041 -
Local Peer STANDARD DIVERSIFIED INC NYSE American 128.873 54.125 - - -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 85.970 - - 37.8571 -
Local Peer CEL-SCI CORP NYSE American 80.103 - - 69.8697 -
Local Peer IBIO INC NYSE American 82.609 - - 11.9624 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 61.391 - - 1.9931 -
Local Peer HEMISPHERX BIOPHARMA INC NYSE American 56.007 - - 10.5153 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 54.428 - - 10.6902 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 43.819 - - - -
Other Local Peers INDIA GLOBALIZATION CAPITAL INC (NYSE American), ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NANOVIRICIDES INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American)
Global Peer AMGEN INC NASDAQ 121,841.252 14.515 15.311 11.2878 2.728
Global Peer GILEAD SCIENCES INC NASDAQ 80,343.588 14.728 13.492 3.5525 3.638
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 106,623.607 39.742 39.742 14.2485 1.138
Global Peer CELGENE CORP NASDAQ 67,514.668 16.687 12.809 6.7172 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 47,222.470 22.526 21.320 9.3142 -
Global Peer BIOGEN INC NASDAQ 42,658.902 9.628 8.058 3.2934 -
Global Peer ILLUMINA INC NASDAQ 41,843.550 50.658 44.609 9.6592 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,532.024 13.309 15.722 3.3346 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,985.615 321.978 18.735 2.4584 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), INCYTE CORPORATION (NASDAQ), SINO BIOPHARM (HKEx), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), IONIS PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), MODERNA INC (NASDAQ), GENSCRIPT BIO (HKEx), Lonza (SGX), ACADIA PHARMACEUTICALS INC (NASDAQ), 3SBIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), TILRAY INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), UNIQURE N.V. (NASDAQ), NATERA INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), EPIZYME INC (NASDAQ), OPKO HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), FRONTAGE (HKEx), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ARVINAS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), RETROPHIN INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), VIVA BIOTECH (HKEx), WAVE LIFE SCIENCES LTD (NASDAQ), MACROGENICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), UROGEN PHARMA LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), POLYNOVO LIMITED (ASX), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), NEXTCURE INC (NASDAQ), PERSONALIS INC (NASDAQ), ASCLETIS-B (HKEx), AKEBIA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AVITA MEDICAL LTD (ASX), INTRA-CELLUAR THERAPIES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MESOBLAST LTD (ASX), SYROS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), DERMIRA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MEDICINOVA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), ESSEX BIO-TECH (HKEx), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), RESTORBIO INC (NASDAQ), XBIOTECH INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), NEXT SCIENCE LTD (ASX), CLOVIS ONCOLOGY INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PROTHENA CORP PLC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), SORRENTO THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LEE'S PHARM (HKEx), GERON CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), COMPUGEN (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), TELIX PHARMACEUTIC (ASX), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), DPHARMA (Bursa), KAMADA (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIASMA INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AFFIMED N V (NASDAQ), NOVAVAX INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), XOMA CORP (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SYNLOGIC INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ENZO BIOCHEM INC (NYSE), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), BBI LIFE SCI (HKEx), BIOXCEL THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), TOCAGEN INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), VERASTEM INC (NASDAQ), SAVARA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PORT (SET), VACCINEX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ORGENESIS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), OTONOMY INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), CURIS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), PHYLOGICA LIMITED (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IMUGENE LIMITED (ASX), IVERIC BIO INC (NASDAQ), CT ENTERPRISE (HKEx), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), REGENT PACIFIC (HKEx), VASCULAR BIOGENICS LTD (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ORTHOCELL LIMITED (ASX), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), EVOGENE LTD (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ZELDA THERAPEUTICS LTD (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ZAFGEN INC (NASDAQ), RHINOMED LIMITED (ASX), CONTRAFECT CORP (NASDAQ), SOPHIRIS BIO INC (NASDAQ), BIOTRON (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), AEVI GENOMIC MEDIC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), EXTRAWELL PHAR (HKEx), BIOCARDIA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCEPT INC (NASDAQ), MEMPHASYS LTD (ASX), SOLIGENIX INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), VICAL INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), HISTOGENICS CORP (NASDAQ), PRECIPIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), TROVAGENE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PATRYS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), REGENEUS LTD (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), BIONOMICS LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), Suntar Eco-City^ (SGX), NOVELION THERAPEUTICS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CELLMID LIMITED (ASX), ATYR PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), GENETIC TECHNOLOGIES (ASX), CYCLACEL PHARMA IN (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), MGRC (Bursa), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), HAO WEN HLDGS (HKEx), ACTINOGEN MEDICAL LTD (ASX), MEGASUN (Bursa), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CCP TECHNOLOGIES LTD (ASX), OPGEN INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), NANOLLOSE LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NEURALSTEM INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), NOVITA HEALTHCARE LTD (ASX), MEDIBIO LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), TRILLIUM THERAPEUTICS INC (NASDAQ), BPH ENERGY LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.038
+10.42 %
10 Days -+0.007
+1.68 %
20 Days --0.061
-13.35 %
Medium Term Return 3 Months --0.099
-19.96 %
6 Months --0.501
-55.71 %
1 Year --0.027
-6.43 %
Long Term Return 2 Years --2.701
-87.14 %
3 Years --7.445
-94.92 %
5 Years --16.401
-97.63 %
Annualised Return Annualised --
-52.68 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.350 - 3.740 Change From 1 Year Low +0.049 % Change From 1 Year Low (%) +13.89
Change From 1 Year High -3.341 % Change From 1 Year High (%) -89.34
2 Years Range 0.350 - 6.800 Change From 2 Years Low +0.049 % Change From 2 Years Low (%) +13.89
Change From 2 Years High -6.401 % Change From 2 Years High (%) -94.14
5 Years Range 0.350 - 38.700 Change From 5 Years Low +0.049 % Change From 5 Years Low (%) +13.89
Change From 5 Years High -38.301 % Change From 5 Years High (%) -98.97
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Aug 2019 0.400 0.410 0.386 0.399 616,229 -
19 Aug 2019 0.387 0.387 0.365 0.383 383,845 -
16 Aug 2019 0.390 0.390 0.365 0.376 285,246 -
15 Aug 2019 0.360 0.377 0.350 0.370 574,753 -
14 Aug 2019 0.395 0.395 0.360 0.361 609,185 -
13 Aug 2019 0.400 0.400 0.369 0.383 424,517 -
12 Aug 2019 0.419 0.419 0.392 0.393 195,876 -
09 Aug 2019 0.410 0.410 0.392 0.399 283,020 -
08 Aug 2019 0.399 0.400 0.390 0.392 240,231 -
07 Aug 2019 0.412 0.412 0.390 0.392 236,627 -
06 Aug 2019 0.443 0.443 0.390 0.410 773,330 -
05 Aug 2019 0.450 0.453 0.425 0.430 584,191 -
02 Aug 2019 0.465 0.465 0.453 0.453 186,716 -
01 Aug 2019 0.450 0.458 0.450 0.451 291,922 -
31 Jul 2019 0.479 0.479 0.450 0.450 270,019 -
30 Jul 2019 0.450 0.456 0.450 0.456 297,046 -
29 Jul 2019 0.456 0.456 0.450 0.451 253,889 -
26 Jul 2019 0.460 0.463 0.450 0.453 235,038 -
25 Jul 2019 0.460 0.460 0.451 0.455 270,397 -
24 Jul 2019 0.468 0.470 0.456 0.460 495,101 -
23 Jul 2019 0.478 0.481 0.463 0.468 473,576 -
22 Jul 2019 0.470 0.472 0.451 0.469 935,152 -
Summary
Current 2 Weeks
(07 Aug 2019 to 20 Aug 2019)
0.412 0.419 0.350 0.399 3,849,529 -
Previous 2 Weeks
(24 Jul 2019 to 06 Aug 2019)
0.468 0.470 0.350 0.410 3,657,649 -
4 Weeks from
(25 Jun 2019 to 23 Jul 2019)
0.479 0.550 0.350 0.468 16,291,790 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.